Ulcerative colitis in children 10 years old or younger

J D Gryboski1

  • 1Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut 06510.

Insights

Pediatric ulcerative colitis often presents with extensive colonic involvement and common symptoms like abdominal pain and diarrhea. Many children experience mild, infrequent recurrences and maintain a good quality of life long-term.

Area of Science:

  • Pediatric Gastroenterology
  • Inflammatory Bowel Disease Research
  • Clinical Pediatrics

Background:

  • Ulcerative colitis (UC) in children diagnosed before age 10 presents unique challenges.
  • Understanding the long-term course and outcomes is crucial for effective management.

Purpose of the Study:

  • To review the onset and clinical course of ulcerative colitis in young children.
  • To evaluate disease extent, severity, symptoms, and long-term outcomes in this cohort.

Main Methods:

  • Retrospective review of 38 children diagnosed with ulcerative colitis at or before 10 years of age.
  • Analysis of clinical presentation, diagnostic findings (radiology, colonoscopy), disease severity, and treatment response over time.

Main Results:

  • Mean age at onset was 5.9 years; 24% had a family history of IBD, 13% had infant cow milk allergy.
  • Initially, 71% had total colonic disease; 53% presented with mild colitis.
  • Long-term, 89% had total colonic disease; most patients experienced mild, infrequent recurrences, with two-thirds having mild disease after 2 years and 75% reporting good quality of life.

Conclusions:

  • Pediatric ulcerative colitis in this cohort often involves extensive colonic disease but frequently follows a manageable course.
  • Most children achieve mild disease activity with infrequent relapses and maintain a good quality of life.
  • Early diagnosis and management are key to favorable long-term outcomes in pediatric ulcerative colitis.

Related Concept Videos

Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation. 
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...